Search results
Results from the WOW.Com Content Network
Patients most likely to benefit from a microvascular decompression have a classic form of trigeminal neuralgia. [6] The diagnosis of this disorder is on the basis of the patients' symptoms and from a neurological examination. No blood test or genetic marker exists to diagnose the disease. An MRI scan can help eliminate other diagnoses. Newer ...
Trigeminal neuralgia (TN or TGN), also called Fothergill disease, tic douloureux, trifacial neuralgia, or suicide disease, is a long-term pain disorder that affects the trigeminal nerve, [7] [1] the nerve responsible for sensation in the face and motor functions such as biting and chewing.
1967: Janetta procedure for trigeminal neuralgia [61] 1989: endoscopic carpal tunnel surgery [62] 1992: Magnetic resonance neurography described. [63] First clinical study on nerve decompressions to relieve symptoms of diabetic peripheral neruopathy. [64] [65] 1994: Diffusion tensor imaging described [66] 1997 endoscopic pudendal nerve ...
The trigeminal nerve.. ATN is usually attributed to inflammation or demyelination, with increased sensitivity of the trigeminal nerve.These effects are believed to be caused by infection, demyelinating diseases, or compression of the trigeminal nerve (by an impinging vein or artery, a tumor, dental trauma, accidents, or arteriovenous malformation) and are often confused with dental problems.
Opioids, while commonly used in chronic neuropathic pain, are not a recommended first or second line treatment. [33] In the short and long term they are of unclear benefit, although clinical experience suggests that opioids like tramadol may be useful for treating sudden onset severe pain [ 34 ] In the intermediate term evidence of low quality ...
The recommended first-line preventive therapy is verapamil, a calcium channel blocker. [ 2 ] [ 49 ] Verapamil was previously underused in people with cluster headache. [ 8 ] Improvement can be seen in an average of 1.7 weeks for episodic cluster headache and 5 weeks for chronic cluster headache when using a dosage of ranged between 160 and 720 ...
Trichloroethylene was used in the treatment of trigeminal neuralgia beginning in 1916. [ 17 ] Pioneered by Imperial Chemical Industries in Britain, under the trade name "Trilene" (from tri chloroethy lene ) , its development was hailed as an anesthetic revolution.
Peter Joseph Jannetta (April 5, 1932 – April 11, 2016) was an American neurosurgeon known for devising microvascular decompression, a surgical procedure to treat trigeminal neuralgia. At the University of Pittsburgh School of Medicine , he was the first Walter Dandy Professor of Neurological Surgery.